Diastolic dysfunction is thought to be an important pathophysiologic component of hypertrophic cardiomyopathy (HCM). However, there are conflicting data on the potential value of the mitral E/e 0 ratio. We examined whether left ventricular outflow tract (LVOT) obstruction influences the value of E/e 0 in predicting outcomes in HCM. 
left ventricular outflow tract (LVOT) obstruction influences the value of E/e 0 in predicting outcomes in HCM. 
Methods and results
Patients who met diagnostic criteria for HCM were enrolled. Diastolic function was assessed with complete twodimensional and Doppler echocardiography. A composite clinical outcome including new onset atrial fibrillation, sustained ventricular tachycardia/fibrillation, heart failure, transplantation, and death was examined over a mean follow-up period of 4.2 years. Among 604 patients, 206 patients had an E/e 0 level > _20. Patients with higher septal E/e 0 level were older, with more severe NYHA class, and more severe LVOT obstruction. Higher E/e 0 was associated with worse event-free survival in non-obstructive group and total HCM cohort. In addition, E/e 0 and LVOT pressure gradient were highly correlated in non-obstructive and total HCM, but not in labile or obstructive group. During follow-up period, 95 patients underwent myectomy. Post-op E/e 0 correlated significantly with LVOT pressure gradient (R = 0.306, P = 0.004). In these patients, post-op E/e 0 was associated with worse event-free survival (log-rank P = 0.030). 
Introduction
Hypertrophic cardiomyopathy (HCM) is the most common inherited cardiac disease characterized by myocardial hypertrophy, disarray, and interstitial fibrosis, and presents with heart failure and sudden death particularly in the young. 1, 2 Although the clinical manifestation of HCM is heterogeneous, the most common symptom is exercise intolerance. 3, 4 The aetiology of exercise intolerance is thought to be varying degrees of dynamic left ventricular outflow tract (LVOT) obstruction, diastolic dysfunction, and ischaemia. [5] [6] [7] Dynamic LVOT obstruction is noted either at rest or with provocation in over 2/3 of HCM patients while diastolic dysfunction of some form is thought to be operative in the majority of patients. 8 Yet, reliable assessment of the diastolic function by non-invasive studies in HCM remains elusive.
In a wide variety of cardiac conditions, the mitral early diastolic inflow to early diastolic tissue velocity (E/e 0 ) ratio has emerged as the most informative parameter that correlates best with LV filling pressure and is the predominant means of assessing diastolic function. 9 However, its role in HCM is debatable due to conflicting data regarding the reliability of E/e 0 ratio in patients with HCM. 10, 11 One study indicated that LV filling pressure can be estimated with reasonable accuracy by E/e 0 ratio in HCM patients. 12 A later report concluded that E/e 0 ratio correlated only modestly with direct measurement of left atrial pressure. 8 Other reports only add to this controversy by demonstrating that elevated septal E/e 0 values may predict particular events. [13] [14] [15] These conflicting reports make it unclear as to how best clinicians may utilize E/e 0 in clinical practice. A potential explanation for these discordant findings may be clinical confounders that were not adequately addressed in prior studies. For instance, the influence of dynamic LVOT obstruction on the predictive capability of E/e 0 ratio in HCM has not been previously examined. Since dynamic LVOT obstruction and diastolic dysfunction are highly prevalent in HCM, we sought to examine the impact of LVOT obstruction on the ability of E/e 0 to predict clinical outcomes.
Methods

Study population and data collection
This study was approved by the Johns Hopkins' Institutional Review Board of the Johns Hopkins Hospital and patients signed informed consent for any procedures performed only for research purposes. Patients with a confirmed diagnosis of HCM based on the generally used diagnostic criteria, i.e. unexplained LV hypertrophy with maximal wall thickness > _15 mm in the absence of other cardiac or systemic cause, 16 were prospectively enrolled in Johns Hopkins HCM Center of Excellence from January 2005 to June 2015. History, physical examination parameters, imaging data and medication/surgical history were obtained as previously detailed. 17 Patients with primary valvular disease causing severe stenosis or regurgitation, a previous history of myectomy or alcohol septal ablation were excluded. The investigation conformed to the principles outlined in the Declaration of Helsinki.
Echocardiography
Standard two-dimensional and Doppler transthoracic echocardiography were performed using a GE Vivid 7 and Vivid E9 ultrasound machine (GE Ultrasound, Milwaukee, Wisconsin) with a multi-frequency phased-array transducer, following a rest/stress protocol with Valsalva, exercise, and amyl nitrate provocation as previously published. 18, 19 Conventional measurements were performed and left ventricular ejection fraction was calculated using the modified biplane Simpson's method. 20 Doppler measurements included mitral inflow early diastolic waves (E), late diastolic (A) wave, and LVOT peak gradient at rest and with provocation (Valsalva maneuver, exercise, amyl nitrite). 18, 21 Following peak resting and stress pressure gradients, classification of HCM was established as non-obstructive (< 30 mmHg at rest and stress), labile (<30 mmHg at rest, > _30 mmHg with stress), and obstructive (> _30 mmHg at rest and stress). 22 Tissue Doppler early peak diastolic wave (e 0 ) was obtained from the apical four-chamber view at the basal level of the septum, thereafter septal E/e 0 was calculated. For patients who underwent myectomy, diastolic performance and residual LVOT pressure gradient were assessed > _6 months after operation.
Clinical outcomes and follow-up
A composite cardiovascular (CV) end-point was defined as the primary outcome, which consisted of: new onset atrial fibrillation, 23 sustained (> _30 s) ventricular tachycardia or fibrillation (VT/VF), 24 new onset or acute on chronic heart failure [defined as deterioration of New York Heart Association (NYHA) functional class to class III or IV] requiring hospitalization, heart transplantation due to end-stage cardiomyopathy, and all-cause death. Recurrent events were not considered as outcomes. Arrhythmic events (AF and sustained VT/VF) were recorded by reviewing clinical visit documents, 24-h Holter monitor, and ICD interrogation reports. New onset or worsening of HF at NYHA class III or IV, stroke, myocardial infarction, and heart transplantation had to be documented in out-patient visits or in-hospital charts. Mortality information was obtained by linking our database to the Social Security Death Index with a followup duration of up to 10 years. During follow-up period, patients who underwent septal reduction therapy prior to any adverse event were censored 1 day prior to surgery. All events were clinically adjudicated by one of two HCM clinical experts (TA and RA) who also reviewed raw data and electronic documentation of all arrhythmic events. Any conflict was resolved by repeat review of the documentation and consensus between the experts. Patients who remained event-free were censored on 30 June 2015, with the longest duration being 10 years.
Statistical analysis
The cut-off point for E/e 0 level on composite CV events was identified by using the inflection points on the receiver operating characteristic (ROC) curve and in concordance with a previously published normative value. 25 Utilizing this pre-set cut-off point, stratified descriptive statistics was performed on patient demographics, haemodynamics, conventional and Doppler echocardiographic parameters and outcomes. Data normality was assessed using kernel density plots as well as Shapiro-Wilk tests. Categorical variables were analysed using the v 2 test. Differences in means for normally distributed variables were compared using a non-paired t-test, while variables with a non-normal distribution were compared using the two-sample Wilcoxon rank-sum test. The association between E/e 0 and LVOT pressure gradient was examined by Pearson's and Spearman's correlation depending on normality as well as by linear regression analysis. The prognostic difference between patients with lower and higher E/e 0 level was analysed by Kaplan-Meier survival analysis, with the significance based on the log-rank test. Cox proportional hazards models were used to identify the predictors of CV events. Covariates that were selected into multivariate model are based on their significance in univariate Cox analysis, which included age, NYHA functional class, use of beta-blocker, left atrium (LA) diameter, interventricular septum thickness, LVOT pressure gradient at rest and HCM subgroups. A P-value of <0.05 was considered statistically significant. The analyses were performed using the statistical package SPSS, version 18 .0 (SPSS Inc., Chicago, IL, USA).
Results
Of the 617 patients, 13 were excluded due to previous myectomy. Finally, 604 patients (mean age 52.7 ± 14.9 years, 63% men) were included in the analysis, with a mean follow-up duration 4.2 ± 2.7 years. During follow-up, 95 patients underwent myectomy and 104 patients developed the specified composite end-point.
Patient characteristics and echocardiographic results
The ROC curve demonstrated that a baseline septal E/e 0 value of 18.4 we defined an abnormal E/e 0 ratio as > _20. 25 Patients with higher E/e 0 (septal E/e 0 > _20) were older, more likely to be women, and had a worse baseline NYHA class ( Table 1) . These patients had larger left atrial diameter, greater ventricular septum thickness, higher mitral E/A ratio, as well as higher resting and stress LVOT gradients. The echocardiography data are summarized in Table 2 .
E/e 0 prediction of outcomes stratified by rest/stress LVOT gradient During follow-up period, 104 patients reached composite end points, including 38 new onset AF, 19 sustained VT/VF, 32 heart failure, 14 all-cause death and one patients performed heart transplantation. Patients with abnormal E/e 0 had more composite CV events (P < 0.001). Higher E/e 0 ratio was associated with lower event-free survival in the total HCM cohort and the non-obstructive HCM ( Figure 1A and B) . On the other hand, there was only marginal difference in the labile group ( Figure 1C) and no difference in the obstructive group between abnormal and normal range of E/e 0 ( Figure 1D ).
Cox survival analysis indicated that a higher E/e 0 was a significant predictor of the composite event in the overall cohort, and in the nonobstructive and labile groups ( Table 3 , Model 1). After adjusting for age, a higher E/e 0 remained predictive only in non-obstructive HCM patients, but not in labile patients ( Table 3 , Model 2). In addition to E/e 0 ratio, age, NYHA class, use of beta-blocker, LA diameter, interventricular septum thickness, LVOT pressure gradient at rest, and at stress also predicted adverse CV events (see Supplementary data online, Table S1 ). After further adjusting for possible confounding variables above, a high E/e 0 ratio > _20 remained associated with clinical events in the entire cohort ( Figure 2B ). Furthermore, a higher E/e 0 ratio after myectomy was again associated with worse 10-year post-op event-free survival (log-rank P = 0.030) (Figure 3) .
Discussion
In the present study, we provide novel insights into the influence of elevated LVOT pressure gradient on the ability of E/e 0 ratio to predict outcomes in HCM. E/e 0 ratio is associated with adverse CV events in the overall HCM cohort. However, its ability to predict outcomes is adversely affected by high LVOT gradients. Thus, E/e 0 had the greatest value in non-obstructive HCM. In the presence of a significant LVOT obstruction, the LVOT gradient itself had a greater impact on future adverse CV events than E/e 0 . The influence of LVOT gradient was confirmed upon examining patient after surgical myectomy.
Post-myectomy E/e 0 value predicted outcomes in these previously obstructive HCM patients.
E/e 0 and outcome prediction
Although there is evidence that E/e 0 does not correlate well with LV filling pressure in HCM, 8 there are data indicating that E/e 0 still provides meaningful clinical information since it correlates with symptoms, exercise capacity, and long term outcomes. 13, 14, 26, 27 A higher E/e 0 has been demonstrated to correlate with NYHA functional class and peak oxygen consumption in HCM patients. 27 It can also predict adverse clinical outcomes including death, cardiac arrest, and VT in children 26 as well as in adults.
13,14
Haemodynamic and mechanical determinants of E/e 0 A fair proportion of symptoms in HCM are attributed to diastolic dysfunction. Disorganized myocardial fibre arrangement and scattered fibrosis are major determinants of impaired LV relaxation in HCM patients. 28 A significant increase in the septal E/e 0 ratio is most likely secondary to both anatomic and haemodynamic abnormalities, especially when the hypertrophy is predominantly septal. Transmitral flow velocities (depicted by E wave) is determined by the pressure gradient and blood volume through the LA to LV, and the change in pressure or volume are further influenced by left atrial pressure, ventricular relaxation, and ventricular suction. 8 On the other hand, mitral annular motion (depicted by e 0 ) is influenced by interstitial fibrosis, 29 myocardial hypertrophy, and global myopathy.
The e 0 velocities were significantly lower in subjects with HCM mutations in comparison with healthy subjects. 30 In addition, the presence of obstruction and its associated load conditions might also have a different impact on diastolic regional myocardial function. 31 
Impact of LVOTobstruction on diastolic function
When there is laminar flow through the cardiac chambers without significant stenosis or regurgitation, both systolic LVOT flow and mitral diastolic inflow approximate the whole stroke volume. A higher blood volume may cause higher trans-mitral inflow as well as greater pressure gradient in LVOT. However, the asymmetrically hypertrophied basal septal septum and systolic anterior motion (SAM) of the mitral leaflet cause LVOT narrowing at mid-to-late systolic phase, accelerating forward flow, and thus raising the LVOT pressure gradient. If present, SAM may also cause mitral regurgitation, which in turn increases diastolic mitral flow velocity (increase E wave) due to volume overload. 32 Consequently, factors other than myocardial relaxation/stiffening, such as valve regurgitation, may alter the E/e 0 ratio. In the presence of significant LVOT obstruction and mitral regurgitation, these haemodynamic factors possibly interfere the relationship between E/e 0 and LV filling pressure. Rest or provoked LVOT obstruction occurs in 60-70% of HCM patients, 33 and has been 
Left ventricular outflow tract obstruction and diastolic dysfunction in hypertrophic cardiomyopathy recognized as a strong, independent predictor for progression of heart failure and death in many landmark publications. 34, 35 Thus, the highly prevalent LVOT obstruction adversely affects the clinical value of E/e 0 ratio in the majority of HCM patients.
We confirmed our hypothesis by examining obstructive HCM patients after septal reduction surgery. In the post-myectomy state, not only the correlation between E/e 0 and LVOT pressure gradient improve significantly but also the ratio now was able to predict adverse outcomes. Surgical myectomy that relieves outflow obstruction results in resolution of severe symptoms and is associated with longterm survival equivalent to that of the general population and superior to that of obstructive HCM patients who do not undergo myectomy. 36 Although myectomy relieves outflow obstruction, it does not completely reverse the underlying myopathy, which may be reason why E/e 0 is able to predict outcomes in the post-myectomy state.
Implications for clinical practice
Diastolic dysfunction is often implicated but difficult to assess in HCM. In the recent guideline on diastolic function, a comprehensive approach is recommended for assessment of LV diastolic function and filling pressures in this specific group, which includes E/e 0 ratio, LA volume index, pulmonary vein atrial reversal velocity, and peak velocity of tricuspid regurgitation jet by continuous wave Doppler. When used alone, however, individual variables have modest correlations with LV filling pressures. Despite the limited ability in predicting LV filling pressure, the E/e 0 ratio as an index of LV diastolic function provides incremental prognostic information in this population. 37 In our cohort, E/e 0 ratio best predicts future adverse outcomes in patients without significant LVOT obstruction. LVOT obstruction, a well-documented strong independent predictor of clinical deterioration, is prevalent in 2/3 of the HCM population. 33 In the other 1/3 HCM patients, absence of LVOT obstruction does not guarantee a benign course. 38 About 10% of the non-obstructive patients were at risk for developing drug-refractory advanced heart failure, 39 but current strategies do not identify these high-risk patients effectively. Thus there remains a clinical need for reliable diastolic function markers to better risk stratify HCM patients. A similar need exists in the management of post-myectomy HCM patient with recurrent symptoms when obstruction has been ruled out. Our data help clarify, and build on previous published data, how to best apply the E/e 0 ratio in these scenarios to help with prognostication.
Study limitations
This was a single, tertiary referral centre cohort, hence, susceptible to a referral bias. However, our cohort characteristics are similar to those reported in a majority of HCM-related publications. 34, 36 The influence of medications on our data was unclear and might affect our results. While our total cohort is relatively large, our subpopulation of post-myectomy patients is smaller (n = 95) but would be the largest cohort examined with regards to diastolic dysfunction. We used septal, not lateral mitral annulus (e 0 ) velocities, therefore, our finding cannot be extrapolated to lateral E/e 0 ratio. We compared the impact of LVOT obstruction before and after surgical myectomy, but not alcohol septal ablation, hence our results may not hold true in the post-ablation population. We used a higher E/e 0 ratio cutoff of 20 in our study based on our statistical analysis (ROC) and a comparison with a cutoff of 14. 37 The higher cutoff provided more clinically relevant information in the HCM cohort. 
Conclusions
E/e 0 ratio predicts adverse CV outcomes principally in nonobstructive HCM patients, even after adjustment for clinical confounders. However, the presence and severity of LVOT obstruction needs to be accounted for when assessing the value of E/e 0 in predicting clinical outcomes in HCM. This predictive ability is not operative in those with obstructive haemodynamics but is restored after surgical myectomy.
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